• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Physical therapy for hip osteoarthritis may not lead to significant benefits

byJeffrey CohenandPriyanka Vedak
May 21, 2014
in Chronic Disease
Reading Time: 3 mins read
Physical therapy for hip osteoarthritis may not lead to significant benefits
Share on FacebookShare on Twitter

Image: PD 

1. There was no significant difference in patient-reported outcomes after 12 weeks of physical therapy versus 12 weeks of placebo physical therapy for hip osteoarthritis. 

2. Participants in the both the physical therapy and placebo physical therapy groups reported a statistically significant decrease in hip osteoarthritis pain and increase in physical function.

 Evidence Rating Level: 2 (Good)            

Study Rundown: Although current guidelines for osteoarthritis recommend the use of physical therapy in disease treatment, there is a paucity of data to support the use of this time consuming and costly intervention. This study randomized individuals with symptomatic hip osteoarthritis to receive 12 weeks of either physical therapy or placebo physical therapy with a 24-week follow-up.  The placebo physical therapy involved the use of placebo ultrasound and gel treatment, while those in the physical therapy group received a more comprehensive treatment regimen including in-person and at-home physical therapy drills and exercises. Improvement was evaluated based on assessments made by a blinded researcher and based on self-reported outcomes captured in a patient follow-up questionnaire.

The results of this study are limited by the relatively small study sample size of 102 participants. Moreover, the chronic, waxing and waning nature of osteoarthritis symptomology may not be captured by the relatively short study follow-up period of 24 weeks. While this study suggests that placebo physical therapy is as effective as physical therapy for hip osteoarthritis, a longer study with more participants should be conducted before treatment recommendations are altered.

RELATED REPORTS

Joint fusion superior to watchful waiting for hallux rigidus 

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

Click to read the study published today in JAMA

Relevant Reading: OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009

In-Depth [randomized controlled trial]: This study randomized 102 individuals with hip osteoarthritis to receive physical therapy or placebo physical therapy for 12 weeks.  At the end of the 36-week follow up (12 weeks of therapy and 24 weeks of post-therapy follow up), 83 individuals were analyzed based on two self-report validated tools for osteoarthritis outcomes.  The difference in pain score between the two groups was 4.3 (-9.9 to 18.6) and the difference between physical function score was 0.7 (-4.5 to 10.6) at the end of the 36-week follow up. Neither of these differences was statistically significant. Pain improvements were measured based on an a 100 mm visual analog scale while improvements in physical function were measured using a 17-item osteoarthritis index ranging from 0 to 68 units. An improvement of 17.7 mm and 5.2 units, respectively, was noted for the physical therapy group. An improvement of 22.9 mm and 5.5 units, respectively, was noted for the placebo group. The relative risk of global overall improvement between the two groups was 0.91 (0.61 to 1.37) at 12 weeks and was 1.10 (0.65 to 1.86) at 36 weeks.

More from this author: Risk-reduction counseling with HIV testing may not decrease rates of sexually transmitted infections, Autoantibodies may precede symptom onset in Sjögren’s Syndrome, Peer based health education program linked to reduced waist circumference, No overall change in the prevalence of obesity in the United States between 2003 and 2012, Ambulances equipped for thrombolysis allow for more rapid stroke treatment 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: osteoarthritis
Previous Post

Unnecessary care in Medicare population found to be prevalent

Next Post

Similar outcomes with Kineflex-L and CHARITE lumbar total disc replacements

RelatedReports

Uninterrupted warfarin therapy safe for endovascular procedures
Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

August 10, 2026
Amyloid may cause distant cerebral hypometabolism in Alzheimer’s
Psychiatry

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

September 4, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis
StudyGraphics

#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis

August 25, 2025
Next Post
Mortality risk higher in pediatric trauma patients with chronic conditions

Similar outcomes with Kineflex-L and CHARITE lumbar total disc replacements

ADHD stimulant treatment associated with changes in BMI trajectory

Weight loss during adulthood linked with long-term cardiovascular benefits

Wound surgical device found ineffective at infection control: ROSSINI Trial

Pasireotide effective in reducing postoperative pancreatic surgery complications

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.